MG
CRSP icon

Marex Group’s CRISPR Therapeutics CRSP Stock Holding History

Marex Group’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.38M Buy
134,097
+6,551
+5% +$346K 0.07% 202
2025
Q4 		$6.69M Buy
127,546
+3,777
+3% +$226K 0.07% 192
2025
Q3 		$8.02M Buy
123,769
+104,286
+535% +$5.99M 0.1% 155
2025
Q2 		$948K Buy
19,483
+692
+4% +$26.8K 0.02% 295
2025
Q1 		$639K Sell
18,791
-5,174
-22% -$219K 0.01% 290
2024
Q4 		$943K Buy
23,965
+1,637
+7% +$77.3K 0.02% 251
2024
Q3 		$1.05M Buy
22,328
+1,742
+8% +$88.4K 0.02% 206
2024
Q2 		$1.11M Buy
20,586
+7,486
+57% +$433K 0.03% 213
2024
Q1 		$893K Buy
13,100
+33
+0.3% +$2.36K 0.03% 188
2023
Q4 		$818K Buy
13,067
+2,389
+22% +$132K 0.03% 241
2023
Q3 		$485K Sell
10,678
-840
-7% -$43.4K 0.07% 116
2023
Q2 		$647K Sell
11,518
-5,368
-32% -$305K 0.12% 115
2023
Q1 		$764K Buy
16,886
+7,036
+71% +$342K 0.1% 134
2022
Q4 		$400K Buy
+9,850
New +$523K 0.06% 190

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GP
GSK plc London $599M AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return